Scrub Capital

Overview

Scrub Capital is a venture capital firm focused on transforming early-stage healthcare investing by leveraging the expertise of clinicians, founders, operators, and technology experts. The firm operates within the healthcare sector, specifically targeting health IT, digital health, tech-enabled services, and class I and II medical devices, while excluding investments in medications and class III devices. Scrub Capital's business model involves writing strategic checks ranging from $100K to $300K into pre-seed, seed, and some Series A opportunities. Additionally, the firm runs Special Purpose Vehicles (SPVs) alongside fund investments when interest is high. The firm serves a diverse clientele, including nurses, pharmacists, physicians, therapists, and other allied health professionals, who are not only clinicians but also experienced founders, builders, operators, and investors. Scrub Capital generates revenue through its investment activities, supporting its clinician members with career diversification programs, hands-on education in angel and venture investing, and hosting private in-person and virtual events. The firm is committed to finding the best healthcare solutions by engaging those who deeply understand real-world challenges. Scrub Capital was founded in 2024 and is headquartered in New York, NY. The firm's leadership includes Managing Partner Dr. Rebecca Mitchell, General Partner Dr. Jonathan Slotkin, and Co-Founder Christina Farr. The firm has a 650-member clinician community that actively participates in deal sourcing, portfolio support, and knowledge-sharing to drive impactful investments. Clinicians benefit from career growth programs that include education in venture investing and exclusive networking opportunities. The community is currently invite-only or by application. Scrub Capital's portfolio includes investments in companies such as Photon Health, Conceivable Life Sciences, and Elion. The firm focuses on early-stage healthcare startups, especially in digital health, health IT, tech-enabled services, and class I/II medical devices. Notable investments include Posterity Health and Conceivable Life Sciences. The firm's fund size ranges from $100K to $300K in pre-seed, seed, and some Series A rounds. Scrub Capital brings frontline clinical insight to venture, embedding clinicians in sourcing, diligence, and portfolio support, offering founders real-world context and access to healthcare's decision-makers. Scrub Capital's mission is to improve patient outcomes through innovative solutions by uniting clinicians and tech experts to reshape early-stage healthcare investing. The firm believes that the best healthcare solutions arise from those who deeply understand real-world challenges, and it leverages its unique model to drive strategic growth in the healthcare sector.

Investment Focus

• Focus on early-stage healthcare startups
• Target sectors: health IT, digital health, tech-enabled services, class I and II medical devices
• Exclude investments in medications and class III devices
• Investment size: $100K to $300K per opportunity
• Geographical focus: United States
• Clinician involvement in deal sourcing, portfolio support, and knowledge-sharing